Title: Unplanned Interruption of Radiotherapy in Head and Neck Cancers: report from a Regional Cancer Centre

Authors: Najmi Arshad Manzoor, Shah Saqib Ahmad, Rasool Malik Tariq, Wani Shaq-ul-Qamar, Jan Yasmeen, Wani Shahid Bashir, Lone Mohammad Maqbool, Afroz Fir, Khan Nazir Ahmad

 DOI:  https://dx.doi.org/10.18535/jmscr/v5i4.90

Abstract

Background and Objectives: Any unplanned interruption in head and neck cancers can affect loco regional control rates. Treatment induced toxicities and radiotherapy equipment breakdown or maintenance are the commonest reasons for treatment interruption. We evaluated occurrence and causes of unplanned interruption of radiotherapy in patients of head and neck cancers receiving radical radiotherapy protocol.

Material and Methods: We conducted a retrospective study of 60 patients enrolled for radical Radiotherapy in our Regional Cancer Centre and recorded all relevant details like; patient characteristics, treatment received as well as details of treatment interruptions.

Observations: Most of the patients were in the age group 55-64 years with males comprising 63.3% of cases. Oral cavity was the commonest subsite involved (33.3%) followed by larynx (23.3%). 60% patients started their radiotherapy within 4 weeks of first visit to our OPD and in only 10% of cases waiting period contributed to delay of more than 4 weeks. The average radiotherapy dose received by patients was 65.4 Gy, and the average fraction number was 32.5. 38 patients (63.3%) received single agent cisplatin based concurrent chemotherapy. The average overall treatment time (OTT), including interruptions, was 50.1 days. Treatment interruption was seen in 46.6% cases, out of which treatment induced toxicity contributed to 71.4% and radiotherapy machine related issues lead to interruption in 28.5% patients. Mucositis was the commonest toxicity observed, in half the patients with interruptions. The treatment breaks were mainly compensated by increasing treatment time for all remaining fractions, as per the departmental protocol and/or by treating them on Saturday of last week also.

Conclusion: All efforts should be made to prevent and minimize the treatment interruptions in patients receiving radiotherapy of head and neck cancers in view of clonogenic repopulation affecting the control rates. At the same time, all interruptions should be properly compensated by a standard departmental protocol.

Keywords: Radiotherapy, Interruption, Head and Neck, Mucositis.  

References

1.      Bese NS, Hendry J, Jeremic B. Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation. Int J Radiat Oncol Biol Phys. 2007;68:654–61.

2.      Guidelines for the management of the unscheduled interruption or prolongation of a radical course of radiotherapy. London: The Royal College of Radiologists; 2002.

3.      Hendry JH, Bentzen SM, Dale RG, et.al: A modeled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy. Clin Oncol 1996; 8: 297- 307.

4.      Bentzen SM, Thames HD. Clinical evidence for tumor clonogen regeneration: interpretations of the data. Radiotherapy & Oncol 1991;22:161–166.

5.      Fowler JF, Lindstrom MJ. Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys 1992;23:457–467.

6.      Barton MB, Keane TJ, Galla T, Maki E. The effect of treatment time and treatment interruption on tumour control following radical radiotherapy of laryngeal cancer. Radiother Oncol 1992; 24: 137–143.

7.      Chen Z, King W, Pearcey R, Kerba M, Mackillop WJ. The relationship between waiting time for radiotherapy and clinical outcomes: A systematic review of the literature. Radiother Oncol 2008; 87:3–16..

8.      Chen M, Jiang GL, Fu XL, et al. The impact of overall treatment time on outcomes in radiation therapy for non–small cell lung cancer. Lung Cancer. 2000;28:11–9.

9.      Perez CA, Michalski J, Mansur D, et al. Impact of elapsed treatment time on outcome of external–beam radiation therapy for localized carcinoma of the prostate. Cancer J. 2004;10:349–56.

10.  N. D. James, M. V. Williams, E. T. Summers, K. Jones, B. Cottier; The Management of Interruptions to Radiotherapy in Head and Neck Cancer: An Audit of the Effectiveness of National Guidelines; Clinical Oncology (2008) 20: 599e605 doi:10.1016/j.clon.2008.05.003

11.  Jensen AR, Nellemann HM, Overgaard J. Tumour progression in waiting time for radiotherapy in head and neck cancer. Radiother Oncol 2007;84:5-10

12.  Sylvia Suelotto Diegues; Rozana Mesquita Ciconelli; Roberto Araujo Segreto Causes of unplanned interruption of radiotherapy Radiol Bras vol.41 no.2 São Paulo Mar./ Apr. 2008

13.  Duncan W, MacDougall H, Kerr G, Downing D. The adverse effect of treatment gaps in the outcome of radiotherapy for laryngeal cancer. Radiother Oncol 1996; 41: 203–207.

14.  Gregory Russo,  Robert Haddad, Marshall Posner, Mitchell Machtay  Radiation Treatment Breaks and Ulcerative Mucositis in Head and Neck Cancer  The Oncologist 2008;13:886 – 898

15.  The timely delivery of radical radiotherapy: standards and guidelines for the management of unscheduled treatment interruptions, Third edition, 2008 Board of Faculty of Clinical Oncology The Royal College of Radiologists

16.  Dale RG, Hendry JH, Jones B, et al. Practical methods for compensating for missed treatment days in radiotherapy, with particular reference to head and neck schedules. Clin Oncol. 2002;14: 382–93.

17.  Chen YP, Tsang NM, Tseng CK, et al. Causes of interruption of radiotherapy in nasopharyngeal carcinoma patients in Taiwan. Jpn J Clin Oncol. 2000;30:230.

Corresponding Author

Dr Arshad Manzoor Najmi

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.